雷尼替丁 T3610

Product Introduction
Bioactivity


英文名: Ranitidine

描述: Ranitidine (HSDB 3925) 是一种选择性的，具有口服活性的组胺 H2 受体拮抗剂，IC50为 3.3 μM。它还一种是CYP2C19和CYP2C9的弱抑制剂，可抑制胃液分泌。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 57 mg/mL(181.3 mM)


关键字: Ranitidine | HSDB3925 | Bacterial | CYPs | secretion | CYP2C9 | CYP2C19 | orally | H2-receptor | HSDB-3925 | Cytochrome P450 | Gastric | inhibit | Histamine Receptor | Inhibitor

相关产品: Atazanavir sulfate | Quinidine sulfate dihydrate | Fipronil | Ayanin | 1-Ethynylnaphthalene | Vorozole | Ranitidine Hydrochloride | MS-PPOH | Rhapontigenin | Benzbromarone

相关库: FDA-Approved Drug Library | Drug Repurposing Compound Library | FDA-Approved & Pharmacopeia Drug Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | GPCR Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | NO PAINS Compound Library

雷尼替丁 T3610信息由TargetMol中国为您提供，如您想了解更多关于雷尼替丁 T3610报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途